Inclusion of cholesterol in DOTAP transfection complexes increases the delivery of DNA to cells in vitro in the presence of serum

Gene Therapy
K CrookD J Porteous

Abstract

The contrast between the relative efficiency of transfection by cationic lipid reagents in vitro and that in vivo is well recognised. One suggested reason for this is the presence of competing polyanionic surfaces in blood and other biological fluids, and even in vitro transfections have to be performed in low-serum medium. In this study we have shown that by preparing cationic lipid reagents based on DOTAP with cholesterol as a second constituent of the bilayer we can achieve significant levels of in vitro transfection in serum concentrations of up to 80% (DOTAP alone did not transfect at all in these conditions). In an effort to explain the behaviour of DOTAP/cholesterol mixes under these conditions, we examined the effect of serum on the transfection complex. We could detect protein bound to each type of cationic lipid complex, but there was no difference in the amount nor in the type of protein bound. DNA within either type of complex which were incubated with increasing amounts of serum remained resistant to digestion with DNase I, and there was no reduction in the condensation of the DNA as measured by ethidium bromide fluorescence. Finally, we measured the attachment and uptake into cells by the different complexes in th...Continue Reading

Citations

Nov 20, 2002·The Journal of Gene Medicine·Franz SchererChristian Plank
Dec 30, 1998·Archives of Pharmacal Research·G M Larson, K D Lee
Feb 22, 2008·The Journal of Membrane Biology·Nuno PenachoMaria C Pedroso de Lima
Jun 15, 1999·Trends in Pharmacological Sciences·D L Ennist
Apr 20, 2001·Advanced Drug Delivery Reviews·M C Pedroso de LimaN Düzgüneş
Jun 28, 2002·International Journal of Pharmaceutics·Crispin R Dass
Dec 5, 2008·Bioconjugate Chemistry·Lin ZhuRam I Mahato
Apr 10, 2009·The Journal of Physical Chemistry. B·Alexandra ZidovskaCyrus R Safinya
Jun 24, 2010·Molecular Pharmaceutics·Long Xu, Thomas J Anchordoquy
May 4, 2001·Anti-cancer Drugs·A G Schatzlein
Apr 15, 2011·Journal of Drug Delivery·Manish ShankerRajagopal Ramesh
Mar 30, 2005·Journal of Biomaterials Science. Polymer Edition·Charles Y CheungAllan S Hoffman
Feb 16, 2012·International Journal of Nanomedicine·Marija BrglesJelka Tomašić
Mar 20, 2012·Therapeutic Delivery·Long XuThomas J Anchordoquy
Apr 6, 2013·Therapeutic Delivery·Jamie L BetkerThomas J Anchordoquy
Jun 7, 2013·Therapeutic Delivery·Cédric SapetNicolas Laurent
Jun 9, 2006·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Luc WasunguDick Hoekstra
Apr 10, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Mengzi ZhangRobert J Lee
Apr 15, 2004·Experimental Neurology·M Teresa Girão da CruzMaria C Pedroso de Lima
Mar 15, 2013·Molecular Pharmaceutics·Rahul K KeswaniDaniel W Pack
Jul 21, 2001·Molecular Membrane Biology·S Audouy, D Hoekstra
May 3, 2014·International Journal of Molecular Sciences·Bieong-Kil KimKyung-Oh Doh
Sep 15, 2010·Expert Opinion on Drug Delivery·Lin Zhu, Ram I Mahato
Nov 22, 2005·Expert Opinion on Drug Delivery·Sérgio SimõesMaria Pedroso de Lima
Jul 22, 2014·Expert Opinion on Drug Delivery·Andrea PensadoAlejandro Sanchez
Nov 7, 2003·Journal of Pharmaceutical Sciences·Tianshun Lian, Rodney J Y Ho
Dec 4, 2003·Journal of Pharmaceutical Sciences·Christopher M WiethoffC Russell Middaugh
Nov 16, 2002·Journal of Pharmaceutical Sciences·Taylor K C ArmstrongThomas J Anchordoquy
Jan 18, 2003·Journal of Pharmaceutical Sciences·Christopher M Wiethoff, C Russell Middaugh
Oct 8, 2011·International Journal of Pharmaceutics·Mamta KapoorSiddhesh D Patil
Nov 25, 2014·Molecular Pharmaceutics·Jamie L Betker, Thomas J Anchordoquy
Sep 18, 2008·Journal of Controlled Release : Official Journal of the Controlled Release Society·A L C CardosoC Culmsee
Apr 4, 2008·International Journal of Pharmaceutics·Xiaogang PanRobert J Lee

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.